Accipiter Capital Management is a New York-based healthcare specialist hedge fund that was founded by Gabe Hoffman in 2002. Prior to launching Accipiter, Hoffman worked at Welch Capital Partners, another New York-based fund, which also focuses on healthcare and prior to Welch, Hoffman followed biotech and pharmaceutical sectors at Paramount Capital, a biotechnology merchant banking firm and a hedge fund manager.
| Fund Name: | Accipiter Capital Management |
| Manager | Gabe Hoffman |
| Portfolio Value | $129,828,000 |
| Change This QTR | +0.95% |
| No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|---|
| 1.) | HLS | 1,048,637 | $17,990 | -23% |
13.85% | |
| 2.) | HMA | 1,920,571 | $14,155 | +14% |
10.9% | |
| 3.) | Hca Holdings Inc |
450,386 | $9,922 | -49% |
7.64% | |
| 4.) | CI | 214,913 | $9,026 | +89% |
6.95% | |
| 5.) | AET | 192,692 | $8,130 | +1% |
6.26% | |
| 6.) | BMRN | 234,025 | $8,046 | +1% |
6.19% | |
| 7.) | STEI | 1,250,000 | $7,200 | +111% |
5.54% | |
| 8.) | TEVA | 163,488 | $6,598 | -38% |
5.08% | |
| 9.) | SNY | 174,180 | $6,365 | +0% |
4.9% | |
| 10.) | MYL | 287,977 | $6,180 | -37% |
4.76% | |
| 11.) | CYH | 284,654 | $4,967 | -19% |
3.82% | |
| 12.) | CUTR | 643,368 | $4,793 | +464% |
3.69% | |
| 13.) | CVH | 157,302 | $4,777 |  |
3.67% | |
| 14.) | CFN | 171,061 | $4,347 |  |
3.34% | |
| 15.) | FVE | 1,397,358 | $4,192 | |
3.22% | |
| 16.) | ZMH | 75,771 | $4,048 | +9% |
3.11% | |
| 17.) | LPNT | 85,100 | $3,161 | -53% |
2.43% | |
| 18.) | Pacira Pharmaceuticals Inc |
254,322 | $2,200 | |
1.69% | |
| 19.) | SCI | 130,449 | $1,389 | +1% |
1.06% | |
| 20.) | ALC | 80,100 | $1,193 | -45% |
0.91% |
